##gff-version 3
##sequence-region Q86U44 1 580
Q86U44	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q86U44	UniProtKB	Chain	2	580	.	.	.	ID=PRO_0000207630;Note=N6-adenosine-methyltransferase catalytic subunit	
Q86U44	UniProtKB	Region	377	378	.	.	.	Note=S-adenosyl-L-methionine binding;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000244|PDB:5K7U,ECO:0000244|PDB:5K7W,ECO:0000244|PDB:5L6D,ECO:0000244|PDB:5L6E,ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337,ECO:0000269|PubMed:27627798;Dbxref=PMID:27281194,PMID:27373337,PMID:27627798	
Q86U44	UniProtKB	Region	396	410	.	.	.	Note=Gate loop 1;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	450	454	.	.	.	Note=Interaction with METTL14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:5IL0,ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	462	479	.	.	.	Note=Interphase loop;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	464	480	.	.	.	Note=Interaction with METTL14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:5IL0,ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	465	478	.	.	.	Note=Positively charged region required for RNA-binding;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	507	515	.	.	.	Note=Gate loop 2;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Region	536	539	.	.	.	Note=S-adenosyl-L-methionine binding;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000244|PDB:5K7U,ECO:0000244|PDB:5K7W,ECO:0000244|PDB:5L6D,ECO:0000244|PDB:5L6E,ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337,ECO:0000269|PubMed:27627798;Dbxref=PMID:27281194,PMID:27373337,PMID:27627798	
Q86U44	UniProtKB	Region	549	550	.	.	.	Note=S-adenosyl-L-methionine binding;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000244|PDB:5K7U,ECO:0000244|PDB:5K7W,ECO:0000244|PDB:5L6D,ECO:0000244|PDB:5L6E,ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337,ECO:0000269|PubMed:27627798;Dbxref=PMID:27281194,PMID:27373337,PMID:27627798	
Q86U44	UniProtKB	Motif	210	215	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Binding site	395	395	.	.	.	Note=S-adenosyl-L-methionine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000244|PDB:5K7U,ECO:0000244|PDB:5K7W,ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337;Dbxref=PMID:27281194,PMID:27373337	
Q86U44	UniProtKB	Binding site	438	438	.	.	.	Note=Interaction with METTL14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Binding site	441	441	.	.	.	Note=Interaction with METTL14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Binding site	513	513	.	.	.	Note=S-adenosyl-L-methionine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5IL1,ECO:0000244|PDB:5IL2,ECO:0000244|PDB:5K7U,ECO:0000244|PDB:5K7W,ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337;Dbxref=PMID:27281194,PMID:27373337	
Q86U44	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q86U44	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:29348140;Dbxref=PMID:16964243,PMID:18669648,PMID:20068231,PMID:23186163,PMID:29348140	
Q86U44	UniProtKB	Modified residue	48	48	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Modified residue	50	50	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Modified residue	219	219	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:29348140;Dbxref=PMID:18669648,PMID:23186163,PMID:29348140	
Q86U44	UniProtKB	Modified residue	243	243	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:29348140;Dbxref=PMID:18669648,PMID:29348140	
Q86U44	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:29348140;Dbxref=PMID:23186163,PMID:29348140	
Q86U44	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Cross-link	177	177	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Cross-link	211	211	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Cross-link	212	212	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Cross-link	215	215	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Alternative sequence	1	284	.	.	.	ID=VSP_007864;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.2	
Q86U44	UniProtKB	Alternative sequence	486	505	.	.	.	ID=VSP_007865;Note=In isoform 2. GVKGNPQGFNQGLDCDVIVA->SSSGAQFNRWSTKKNHLISY;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.2	
Q86U44	UniProtKB	Alternative sequence	506	580	.	.	.	ID=VSP_007866;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.2	
Q86U44	UniProtKB	Natural variant	406	406	.	.	.	ID=VAR_076859;Note=Found in patients with large intestine cancer%3B unknown pathological significance%3B does not affect interaction with METTL14%3B abolished RNA methyltransferase activity in vitro. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27373337;Dbxref=PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	2	2	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-43%3B A-48 and A-50. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-2%3B A-48 and A-50. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-2%3B A-43 and A-50. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	50	50	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-2%3B A-43 and A-48. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	177	177	.	.	.	Note=In 4KR%3B strongly decreased sumoylation%3B when associated with 211-R--R-215. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Mutagenesis	211	215	.	.	.	Note=Abolishes localization to the nucleus. KKSRK->GGSGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	211	215	.	.	.	Note=In 3KR%3B decreased sumoylation. In 4KR%3B strongly decreased sumoylation%3B when associated with R-177. KKSRK->RRSRR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29506078;Dbxref=PMID:29506078	
Q86U44	UniProtKB	Mutagenesis	219	219	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-243 and 348-A--A-350. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	243	243	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-219 and 348-A--A-350. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	294	294	.	.	.	Note=Abolishes methyltransferase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27373337;Dbxref=PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	326	326	.	.	.	Note=Abolishes methyltransferase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27373337;Dbxref=PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	348	350	.	.	.	Note=Does not affect nuclear localization%2C interaction with METTL14 or WTAP or catalytic activity%3B when associated with A-219 and A-243. TPS->APA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29348140;Dbxref=PMID:29348140	
Q86U44	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Abolishes methyltransferase activity. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	395	398	.	.	.	Note=Loss of function. Abolishes ability to regulate primary miRNA processing. Does not affect ability to promote mRNA translation. Abolishes formation of m6A at DNA damage sites. DPPW->APPA;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25799998,ECO:0000269|PubMed:27117702,ECO:0000269|PubMed:27627798,ECO:0000269|PubMed:28297716;Dbxref=PMID:25799998,PMID:27117702,PMID:27627798,PMID:28297716	
Q86U44	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Abolishes methyltransferase activity. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27373337;Dbxref=PMID:27281194,PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	406	406	.	.	.	Note=Strong reduction in methyltransferase activity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27627798;Dbxref=PMID:27627798	
Q86U44	UniProtKB	Mutagenesis	462	479	.	.	.	Note=Impaired RNA-binding and methyltransferase activities. QLQRIIRTGRTGHWLNHG->AAAAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Decreased methyltransferase activity. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27373337;Dbxref=PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Decreased methyltransferase activity. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27373337;Dbxref=PMID:27373337	
Q86U44	UniProtKB	Mutagenesis	532	532	.	.	.	Note=Abolishes methyltransferase activity. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	536	536	.	.	.	Note=Slight reduction in methyltransferase activity. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	538	538	.	.	.	Note=Slight reduction in methyltransferase activity. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	539	539	.	.	.	Note=Abolishes methyltransferase activity. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27281194;Dbxref=PMID:27281194	
Q86U44	UniProtKB	Mutagenesis	549	549	.	.	.	Note=Slight reduction in methyltransferase activity. Strong reduction in methyltransferase activity%3B when associated with A-550. N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27627798;Dbxref=PMID:27281194,PMID:27627798	
Q86U44	UniProtKB	Mutagenesis	550	550	.	.	.	Note=Slight reduction in methyltransferase activity. Strong reduction in methyltransferase activity%3B when associated with A-549. Q->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:27281194,ECO:0000269|PubMed:27627798;Dbxref=PMID:27281194,PMID:27627798	
Q86U44	UniProtKB	Sequence conflict	251	251	.	.	.	Note=N->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86U44	UniProtKB	Sequence conflict	263	264	.	.	.	Note=KF->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86U44	UniProtKB	Sequence conflict	382	382	.	.	.	Note=D->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86U44	UniProtKB	Sequence conflict	568	568	.	.	.	Note=R->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86U44	UniProtKB	Beta strand	372	376	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Turn	378	380	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	383	386	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	390	394	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	411	416	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	419	422	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	424	432	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	436	446	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	450	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	464	466	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	473	477	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	480	489	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	498	506	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	510	512	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	516	524	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	530	534	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	537	539	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	544	548	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Beta strand	553	555	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
Q86U44	UniProtKB	Helix	559	568	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5IL2	
